Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
暂无分享,去创建一个
B. Han | B. Zhou | R. Goldin | R. Ramakrishnan | S. Ramachandran | Jiong Deng | Nicole Strittmatter | L. Muirhead | Xiao-feng Ye | Yongxu Zhao | Y. E. Chin | Dongliang Xu | Jingyi Liu | Qi Li | Jie Zhang | Beibei Sun | Yong Gao | David C. Dorn | Zhi Pang | P. Jobling | Wenzheng Guo | Ruixu Yang | Jay Pundavela | Shuli Liu | Xiaofeng Lin | Yueling Liao | Hongyong Song | F. Yao | S. M. Oliveira | Huijing Yin | Shuangshuang Zhong | Chengyi Ding | Huike Jiao | M. A. Moore | Sabine Guenther | Lina Ma | Marjorie M. Walker | A. Speller | everine Roselli
[1] Gregory A. Wyant,et al. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1 , 2015, Science.
[2] Wei Liu,et al. Proline metabolism and cancer: emerging links to glutamine and collagen , 2014, Current opinion in clinical nutrition and metabolic care.
[3] G. Superti-Furga,et al. SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.
[4] S. Estrach,et al. CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction. , 2014, Cancer research.
[5] Y. Bhutia,et al. The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy , 2014 .
[6] B. Han,et al. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer , 2014, Molecular Cancer.
[7] G. Semenza,et al. Hypoxia-inducible factors enhance glutamate signaling in cancer cells , 2014, Oncotarget.
[8] N. Samadi,et al. Akt and p53R2, partners that dictate the progression and invasiveness of cancer. , 2014, DNA repair.
[9] J. Rasko,et al. Targeting glutamine transport to suppress melanoma cell growth , 2014, International journal of cancer.
[10] R. Chen,et al. The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation , 2014, The Journal of cell biology.
[11] Timothy D. Johnson,et al. Macroscopic Stiffness of Breast Tumors Predicts Metastasis , 2014, Scientific Reports.
[12] Jae-Hoon Chang,et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. , 2014, Immunity.
[13] B. Gary,et al. Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention , 2014, Medicinal Chemistry Research.
[14] R. Rola,et al. Glutamate and its receptors in cancer , 2014, Journal of Neural Transmission.
[15] J. Arthur,et al. The Catalytic Subunit of the System L1 Amino Acid Transporter (Slc7a5) Facilitates Nutrient Signalling in Mouse Skeletal Muscle , 2014, PloS one.
[16] Y. Kanai,et al. JPH203, an L-type amino acid transporter 1-selective compound, induces apoptosis of YD-38 human oral cancer cells. , 2014, Journal of pharmacological sciences.
[17] A. Hartmann,et al. Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11 , 2014, Clinical Cancer Research.
[18] N. Siafakas,et al. Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction , 2013, European journal of clinical investigation.
[19] Hong-Yang Wang,et al. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. , 2013, Gastroenterology.
[20] M. Verschoor,et al. Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer , 2013, Molecular Cancer.
[21] J. Gray,et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. , 2013, Cancer cell.
[22] J. Locasale. Serine, glycine and one-carbon units: cancer metabolism in full circle , 2013, Nature Reviews Cancer.
[23] A. Karameris,et al. Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis , 2013, BioMed research international.
[24] A. Edinger,et al. Nutrient transporters: the Achilles’ heel of anabolism , 2013, Trends in Endocrinology & Metabolism.
[25] D. Fotiadis,et al. The SLC3 and SLC7 families of amino acid transporters. , 2013, Molecular aspects of medicine.
[26] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[27] P. Kalivas,et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. , 2013, Antioxidants & redox signaling.
[28] A. Lane,et al. Control of Glutamine Metabolism By the Tumor Suppressor Rb , 2013, Oncogene.
[29] M. Malumbres,et al. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. , 2012, Molecular cell.
[30] Edward S. Kim,et al. g-Protein Coupled Receptor Family C, Group 5, Member A (gprc5a) Expression Is Decreased in the Adjacent Field and Normal Bronchial Epithelia of Patients with Chronic Obstructive Pulmonary Disease and Non–Small-Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[31] Y. Jeng,et al. CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation , 2012, Cell Death and Differentiation.
[32] W. Pao,et al. Chipping away at the lung cancer genome , 2012, Nature Medicine.
[33] R. Lotan,et al. Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation , 2012, Molecular Cancer.
[34] V. Ganapathy,et al. SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer* , 2011, The Journal of Biological Chemistry.
[35] Guoqiang Chen,et al. MicroRNA‐26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11 , 2011, FEBS letters.
[36] Z. Bacso,et al. miR‐126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5 , 2011, FEBS letters.
[37] M. Ohmura,et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.
[38] R. Lotan,et al. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor. , 2010, Cancer research.
[39] T. Goldkorn,et al. Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. , 2010, American journal of respiratory cell and molecular biology.
[40] C. Thompson,et al. Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.
[41] R. Lotan,et al. Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-κB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis , 2010, Cancer Prevention Research.
[42] S. Wakana,et al. xCT deficiency accelerates chemically induced tumorigenesis , 2010, Proceedings of the National Academy of Sciences.
[43] P. Blower,et al. Pharmacogenomic Approach Reveals a Role for the xc− Cystine/Glutamate Antiporter in Growth and Celastrol Resistance of Glioma Cell Lines , 2010, Journal of Pharmacology and Experimental Therapeutics.
[44] Chi V Dang,et al. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.
[45] Y. Kanai,et al. l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth , 2010, Cancer science.
[46] J. Fostel,et al. Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis , 2009, Molecular Cancer.
[47] Suimin Qiu,et al. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. , 2009, Cancer cell.
[48] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[49] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[50] N. Sunaga,et al. l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms , 2008, Cancer science.
[51] D. Munn,et al. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. , 2008, The Biochemical journal.
[52] L. Dwyer-Nield,et al. Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice , 2008, Cancer Chemotherapy and Pharmacology.
[53] Yuzhuo Wang,et al. The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance , 2008, British Journal of Cancer.
[54] I. Wistuba,et al. Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer , 2008, PloS one.
[55] Jonghwan Kim,et al. Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo , 2008, PloS one.
[56] Ron Bose,et al. Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface , 2007, Nature.
[57] R. Lotan,et al. Identification of the Retinoic Acid – Inducible Gprc5a as a New Lung Tumor Suppressor Gene , 2022 .
[58] H. Sontheimer,et al. Autocrine glutamate signaling promotes glioma cell invasion. , 2007, Cancer research.
[59] M. Meyerson,et al. Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. , 2007, Cancer cell.
[60] David J Riese,et al. Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[61] Daniel A. Haber,et al. Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.
[62] Y. E. Chin,et al. Stat3 Cleavage by Caspases , 2006, Journal of Biological Chemistry.
[63] R. Issels,et al. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death , 2006, Oncogene.
[64] Satoru Takahashi,et al. Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice* , 2005, Journal of Biological Chemistry.
[65] Ying Huang,et al. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. , 2005, Cancer research.
[66] A. Hartmann,et al. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. , 2005, International journal of oncology.
[67] T. Jacks,et al. Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.
[68] Sheng-Chieh Hsu,et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. , 2005, Cancer cell.
[69] W. R. Bishop,et al. Integrative Genomics Revealed RAI3 Is a Cell Growth-promoting Gene and a Novel P53 Transcriptional Target* , 2005, Journal of Biological Chemistry.
[70] S. Shapiro,et al. Normal lung development in RAIG1-deficient mice despite unique lung epithelium-specific expression. , 2005, American journal of respiratory cell and molecular biology.
[71] M. Hung,et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.
[72] I. Amit,et al. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation , 2004, The EMBO journal.
[73] A. Holmgren,et al. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. , 2004, Antioxidants & redox signaling.
[74] R. Henriksson,et al. LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis , 2003, British Journal of Cancer.
[75] M. Tsurudome,et al. The targeted disruption of the CD98 gene results in embryonic lethality. , 2003, Biochemical and biophysical research communications.
[76] G. Scagliotti,et al. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. , 2003, Lung cancer.
[77] Huang Shao,et al. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. , 2003, Cancer research.
[78] M. Hung,et al. β-catenin interacts with and inhibits NF-κB in human colon and breast cancer , 2002 .
[79] S. Bröer. Adaptation of plasma membrane amino acid transport mechanisms to physiological demands , 2002, Pflügers Archiv.
[80] R. Martindale,et al. Cloning and functional characterization of a new subtype of the amino acid transport system N. , 2001, American journal of physiology. Cell physiology.
[81] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[82] R. Martindale,et al. Structure, function, and tissue expression pattern of human SN2, a subtype of the amino acid transport system N. , 2001, Biochemical and biophysical research communications.
[83] M. Nau,et al. cbl-b inhibits epidermal growth factor receptor signaling , 1999, Oncogene.
[84] V. Ganapathy,et al. Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. , 1999, Biochemical and biophysical research communications.
[85] R. Lotan,et al. Molecular Cloning and Characterization of a Novel Retinoic Acid-inducible Gene That Encodes a Putative G Protein-coupled Receptor* , 1998, The Journal of Biological Chemistry.
[86] H. Koeffler,et al. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. , 1996, Cancer research.
[87] P. Taylor. Role of amino acid transporters in amino acid sensing. , 2014, The American journal of clinical nutrition.
[88] S. Bröer. The SLC38 family of sodium–amino acid co-transporters , 2013, Pflügers Archiv - European Journal of Physiology.
[89] R. Ciurea,et al. EGFR, HER2÷neu and Ki67 immunoexpression in serous ovarian tumors. , 2012, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[90] M. Yuen,et al. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. , 2011, Experimental and therapeutic medicine.
[91] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[92] V. Ganapathy,et al. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. , 2009, Pharmacology & therapeutics.
[93] V. Ganapathy,et al. Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.
[94] V. Ganapathy,et al. Cellular uptake of amino acids: Systems and regulation , 2003 .
[95] M. Hung,et al. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. , 2002, Cancer cell.